Similar articles

• Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.

  Nogae I, Kohno K, Kikuchi J, Kuwano M, Akiyama S, Kiue A, Suzuki K, Yoshida Y, Cornwell MM, Pastan I, et al. Nogae I, et al. Biochem Pharmacol. 1989 Feb 1;38(3):519-27. doi: 10.1016/0006-2952(89)90393-6. Biochem Pharmacol. 1989. PMID: 2563655
• Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.

  Yang CP, Mellado W, Horwitz SB. Yang CP, et al. Biochem Pharmacol. 1988 Apr 1;37(7):1417-21. doi: 10.1016/0006-2952(88)90803-9. Biochem Pharmacol. 1988. PMID: 2895656 No abstract available.
• P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid.

  Wolf DC, Horwitz SB. Wolf DC, et al. Int J Cancer. 1992 Aug 19;52(1):141-6. doi: 10.1002/ijc.2910520125. Int J Cancer. 1992. PMID: 1354202
• Multidrug resistance and its circumvention.

  Beck WT. Beck WT. Eur J Cancer. 1990 Apr;26(4):513-5. doi: 10.1016/0277-5379(90)90028-r. Eur J Cancer. 1990. PMID: 1972629 Review. No abstract available.
• Multidrug resistance in human cancer.

  Goldstein LJ, Pastan I, Gottesman MM. Goldstein LJ, et al. Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w. Crit Rev Oncol Hematol. 1992. PMID: 1353966 Review. No abstract available.